ChemicalBook > CAS DataBase List > AG 1295

AG 1295

Product Name
AG 1295
CAS No.
71897-07-9
Chemical Name
AG 1295
Synonyms
AG 1295;NSC 380341;AG 1295 USP/EP/BP;TYRPHOSTIN AG 1295;TYROPHOSTIN AG1295;AG-1295 (NSC 380341;TYRPHOSTIN AG 1295, 99+%;AG 1295 PLATELET-DERIVED GROW;6,7-DIMETHYL-2-PHENYLQUINOXALINE;Quinoxaline, 6,7-dimethyl-2-phenyl-
CBNumber
CB5683675
Molecular Formula
C16H14N2
Formula Weight
234.3
MOL File
71897-07-9.mol
More
Less

AG 1295 Property

Melting point:
121 °C
Boiling point:
398.3±37.0 °C(Predicted)
Density 
1.127±0.06 g/cm3(Predicted)
storage temp. 
−20°C
solubility 
Chloroform (Slightly), Ethyl Acetate (Slightly)
form 
White solid
pka
1.29±0.30(Predicted)
color 
Yellow
More
Less

Safety

Safety Statements 
22-24/25
WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
658550
Product name
AG 1295
Packaging
5mg
Price
$159
Updated
2024/03/01
Sigma-Aldrich
Product number
R365327
Product name
6,7-DIMETHYL-2-PHENYL-QUINOXALINE
Purity
AldrichCPR
Packaging
25MG
Price
$28.6
Updated
2023/06/20
Cayman Chemical
Product number
14529
Product name
AG 1295
Purity
≥98%
Packaging
1mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
14529
Product name
AG 1295
Purity
≥98%
Packaging
5mg
Price
$100
Updated
2024/03/01
Cayman Chemical
Product number
14529
Product name
AG 1295
Purity
≥98%
Packaging
10mg
Price
$184
Updated
2024/03/01
More
Less

AG 1295 Chemical Properties,Usage,Production

Description

Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds which act as PTK blockers. PTK inhibitors specific for platelet-derived growth factor (PDGF) receptor kinase could help in the treatment of atherosclerosis, restenosis, pulmonary fibrosis, and gliomas. AG-1295 is a quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGF receptor kinase in vitro and in Swiss 3T3 cells (IC50s range from 0.3-1 μM). It inhibits PDGF-stimulated DNA synthesis with an IC50 value of 2.5 μM without affecting activity of the EGF receptor.

Uses

AG-1295 is a protein tyrosine kinase inhibitor. Antiproliferative agent used in the treatment of atherosclerosis, pulmonary fibrosis, and gliomas.

Definition

ChEBI: 6,7-dimethyl-2-phenylquinoxaline is a quinoxaline derivative. It has a role as a geroprotector.

in vitro

the previous study investigated the effect of pdgf receptor-beta (pdgfr-β) inhibition by ag-1295 on the osteogenic differentiation of the mouse pre-osteoblastic cell line mc3t3-e1. results showed that ag-1295 could significantly increase the alkaline phosphatase (alp) activity and enhance the formation of mineralized nodules dose-dependently. moreover, the treatment with ag-1295 led to the up-regulated mrna expression of the osteogenic marker genes collagen type i, runt-related transcription factor 2, osterix, tissue-nonspecific alkaline phosphatase, as well as osteocalcin. consistent with its effect on osteoblast differentiation, ag-1295 was also able to significantly suppress the phosphorylation of erk1/2 in mc3t3-e1 cells [1].

in vivo

a previous animal study was designed to evaluated the possible effects of ag1295 on the development of interstitial fibrosis in rats with unilateral ureteral obstruction, monitored by ed-a+ fibronectin expression, the number of macrophages. results showed that the i.p.treatment with ag1295 at 12 mg/kg could significantly reduce interstitial fibrosis as verified by a smaller sirius-red stained area and also by a reduced number of macrophages, and by the ed-a+ fibronectin deposition and the number of cells positive for α-smooth muscle actin [2].

IC 50

0.3-1 μm for pdgf receptor kinase in vitro and in swiss 3t3 cells

References

[1] zhang yy, cui yz, luan j, zhou xy, zhang gl, han jx. platelet-derived growth factor receptor kinase inhibitor ag-1295 promotes osteoblast differentiation in mc3t3-e1 cells via the erk pathway. biosci trends. 2012 jun;6(3):130-5.
[2] ludewig d, kosmehl h, sommer m, bhmer fd, stein g. pdgf receptor kinase blocker ag1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction. cell tissue res. 2000 jan;299(1):97-103.

AG 1295 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

View Lastest Price from AG 1295 manufacturers

Career Henan Chemical Co
Product
AG 1295 71897-07-9
Price
US $1.00/KG
Min. Order
1KG
Purity
98-100%
Supply Ability
1000kg
Release date
2018-08-20

71897-07-9, AG 1295Related Search:


  • 6,7-DIMETHYL-2-PHENYLQUINOXALINE
  • AG 1295
  • TYROPHOSTIN AG1295
  • TYRPHOSTIN AG 1295
  • AG 1295 PLATELET-DERIVED GROW
  • TYRPHOSTIN AG 1295, 99+%
  • Quinoxaline, 6,7-dimethyl-2-phenyl-
  • AG-1295 (NSC 380341
  • NSC 380341
  • AG 1295 USP/EP/BP
  • Platelet-derived growth factor receptor,RTK,AG 1295,inhibit,PDGF-receptor,AG-1295,autophosphorylation,Inhibitor,AG1295,PDGFR
  • 71897-07-9
  • 70897-07-9
  • Cell Signaling and Neuroscience
  • Cell Biology
  • BioChemical
  • Kinase/Phosphatase Biology
  • Receptor Tyrosine Kinase Inhibitors
  • Platelet Derived Growth Factor Receptor (PDGFR)